| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10919836 | Radiotherapy and Oncology | 2011 | 7 Pages |
Abstract
Despite no dosimetric benefits with respect to target volume and an MU increase, a definite dose reduction was observed at the spinal cord for smaller beamlet sizes. Treatment with IMRS planning for the spine will benefit from the use of a beamlet size between 2 and 4Â mm.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Joo Young Kim, Hyun Soo Shin, Ja Young Kim, Hyeli Park, Sung Joon Kim,